EDIT Q3 2022 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$42,000-99.3% YoY

Gross Profit

-$41M-98295.2% margin

Operating Income

-$58M-136952.4% margin

Net Income

-$56M-132681.0% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

-99.3%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$49M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$531M

Total Liabilities

$116M

Stockholders' Equity

$415M

Cash & Equivalents

$211M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42,000	$6M	-99.3%
Gross Profit	-$41M	-$23M	-79.0%
Operating Income	-$58M	-$39M	-46.5%
Net Income	-$56M	-$39M	-42.6%